Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print RSS Feed

Breaking News

Related Searches: Promotions & Moves

June 9, 2011
Brad Benson, Ph.D., has joined the CMC Development Services team at ABC Laboratories.   Read More »

June 9, 2011
Hovione and Particle Sciences Inc (PSI) have entered a collaboration to combine their technologies in an effort to speed development projects targeting poorly water-soluble drugs.   Read More »

June 9, 2011
Advanced BioScience Laboratories, Inc. (ABL) has opened its new research and manufacturing facility following the expansion of its vaccine and biotherapeutic product development capabilities at its new headquarters in Rockville, MD.  Read More »

June 9, 2011
Celerion’s clinical research operations in Belfast, Northern Ireland, and its clinical research and bioanalytical services operations in Lincoln, NE, have been certified by the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária – ANVISA). ANVISA provides regulatory approval for drugs and other products seeking to enter the Brazilian market.  Read More »

June 8, 2011
Todd Meyers has been appointed vice president of sales and marketing at ACM Global Central Lab, responsible for global business development efforts.  Read More »

June 8, 2011
SGS North America, Inc. has been certified to conduct thermal testing on insulated shipping containers used in the transport of temperature-sensitive products, such as pharmaceuticals, under the new International Safe Transit Association (ISTA) Standard 20 certification/testing procedures and Standard 7E Thermal Profiles.  Read More »

June 8, 2011
Lonza is investing nearly $12 million to expand its biopharmaceutical development services in Singapore.  Read More »

June 8, 2011
Merck and Intercell AG have terminated the Phase II/III trial investigating Staphylococcus aureus vaccine, V710, following analysis of the trial data and the unanimous recommendation by an independent Data Monitoring Committee (DMC).  Read More »

June 7, 2011
Biogen Idec received approval from the European Commission for its Avonex Pen for patients with relapsing multiple sclerosis (MS) and patients who have had a single demyelinating event.  Read More »

June 7, 2011
Paul Rubin, M.D., has been appointed vice president and chief medical officer at XOMA Ltd.   Read More »

June 7, 2011
Pierre Geoffroy, M.D., CM, MSc, FCFP has been appointed vice president of Early Stage at Kendle.   Read More »

June 7, 2011
Pfenex Inc. has entered into a non-exclusive strategic partnership with SAFC, a unit of the Sigma-Aldrich Corp., under which Pfenex will engineer production strains and processes for SAFC’s contract manufacturing customers.   Read More »

June 6, 2011
Patrys Ltd. has extended its relationship with Laureate Biopharmaceutical Services, Inc., to manufacture its lead product PAT-LM1 for preclinical and clinical use.   Read More »

June 6, 2011
Protea Biosciences began offering bioanalytical services employing LAESI imaging mass spectrometry, a new technology for rapid and comprehensive identification of biomolecules in tissues and biofluids.  Read More »

June 6, 2011
Evotec AG has entered into a medicinal chemistry collaboration with Active Biotech AB, following the successful conclusion of a High Throughput Screening campaign to identify small molecule modulators of Active Biotech’s priority biological target involved in immune disorders and cancer.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On